Gradient Investments LLC Novavax Inc Transaction History

Gradient Investments LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$3.76 - $6.02 $6,948 - $11,124	-1,848 Reduced 78.71%	500 $2,000
Q3 2023 Oct 27, 2023	SELL	$6.81 - $9.74 $1,123 - $1,607	-165 Reduced 6.57%	2,348 $16,000
Q2 2023 Jul 11, 2023	SELL	$6.67 - $9.52 $1,460 - $2,084	-219 Reduced 8.02%	2,513 $18,000
Q1 2023 Apr 17, 2023	BUY	$5.76 - $12.48 $2,211 - $4,792	384 Added 16.35%	2,732 $18,000
Q2 2022 Jul 11, 2022	BUY	$36.28 - $75.29 $39,908 - $82,819	1,100 Added 88.14%	2,348 $121,000
Q1 2022 May 26, 2022	SELL	$69.73 - $142.9 $5,438 - $11,146	-78 Reduced 5.88%	1,248 $92,000
Q4 2021 Jan 12, 2022	BUY	$134.56 - $217.97 $23,413 - $37,926	174 Added 15.1%	1,326 $190,000
Q3 2021 Oct 18, 2021	BUY	$177.8 - $270.58 $10,312 - $15,693	58 Added 5.3%	1,152 $239,000
Q2 2021 Jul 12, 2021	BUY	$121.0 - $257.67 $47,190 - $100,491	390 Added 55.4%	1,094 $232,000
Q1 2021 Apr 21, 2021	BUY	$112.98 - $319.93 $56,941 - $161,244	504 Added 252.0%	704 $128,000
Q3 2020 Oct 06, 2020	BUY	$79.44 - $178.51 $15,888 - $35,702	200 New	200 $22,000

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $704M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Gradient Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Gradient Investments LLC with notifications on news.